Filter:

Prostate Cancer Webinars

An Oculus Virtual Reality View: The Role of Emergency Physicians in the Management of Immune-Related Adverse Events in Patients Treated with Immuno-oncology Agents

An Oculus Virtual Reality View: The Role of Emergency Physicians in the Management of Immune-Related Adverse Events in Patients Treated with Immuno-oncology Agents

This online activity is focused on the identification and exploration of immune-related adverse events, their management, and the critical role of emergency department physicians in the care of patients treated with immune checkpoint inhibitors.

Release Date: November 21, 2019
Expiration Date: November 21, 2020

Learn More & View Event »

Considerations for Oncology Nurses—Individualizing the Management of Acute Myeloid Leukemia: Genomics, Targeted Therapeutic Options, and Treatment Sequencing

Considerations for Oncology Nurses—Individualizing the ManaThis online activity will cover the treatment and management of patients with Acute Myeloid Leukemia (AML).

This online activity will cover the treatment and management of patients with Acute Myeloid Leukemia (AML).

Release Date: December 16, 2019
Expiration Date: December 16, 2020

Learn More & View Event »

Combating T-cell Dysfunction in Cutaneous Squamous Cell Carcinoma: Integrating Checkpoint Inhibitors into Clinical Practice and Managing Adverse Events

Combating T-cell Dysfunction in Cutaneous Squamous Cell Carcinoma: Integrating Checkpoint Inhibitors into Clinical Practice and Managing Adverse Events

This enduring activity is focused on the management of patients with advanced or metastatic cutaneous squamous cell carcinoma.

Release Date: January 31, 2020
Expiration Date: January 31, 2021

Learn More & View Event »

An Oculus Virtual Reality View: The Role of Emergency Physicians in the Management of Immune-Related Adverse Events in Patients Treated with Immuno-oncology Agents

An Oculus Virtual Reality View: The Role of Emergency Physicians in the Management of Immune-Related Adverse Events in Patients Treated with Immuno-oncology Agents

This online activity is focused on the identification and exploration of immune-related adverse events, their management, and the critical role of emergency department physicians in the care of patients treated with immune checkpoint inhibitors.

Release Date: February 10, 2020
Expiration Date: February 10, 2021

Learn More & View Event »

Improving the Care of Patients with Persistent Hypercholesterolemia by Decreasing Cardiovascular Risk Using PCSK9 Inhibitors: A Comprehensive Infographic View

Improving the Care of Patients with Persistent Hypercholesterolemia by Decreasing Cardiovascular Risk Using PCSK9 Inhibitors: A Comprehensive Infographic View

This enduring activity is focused on the care of patients with chronic rhinosinusitis with nasal polyps.

Release Date: February 21, 2020
Expiration Date: February 21, 2021

Learn More & View Event »

A Virtual Reality View New Approaches to the Diagnosis and Treatment of Pediatric and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis

A Virtual Reality View New Approaches to the Diagnosis and Treatment of Pediatric and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis

While guidelines regarding the management of AD in children have been published, variability persists in practice. Treatment inconsistencies and the chronic and relapsing nature of AD can lead to frustration for patients, family, and caregivers when managing AD. This program will focus on providing AD caregivers an update on recent pathophysiological findings that drive new therapeutic targets; reviewing severity and diagnosis of AD; and discussing the clinical profiles of existing and emerging agents, with focus on treatment individualization.

Release Date: June 11, 2020
Expiration Date: June 11, 2021

Learn More & View Event »

A Virtual Reality View New Approaches to the Diagnosis and Treatment of Pediatric and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis

A Virtual Reality View New Approaches to the Diagnosis and Treatment of Pediatric and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis

While guidelines regarding the management of AD in children have been published, variability persists in practice. Treatment inconsistencies and the chronic and relapsing nature of AD can lead to frustration for patients, family, and caregivers when managing AD. This program will focus on providing AD caregivers an update on recent pathophysiological findings that drive new therapeutic targets; reviewing severity and diagnosis of AD; and discussing the clinical profiles of existing and emerging agents, with focus on treatment individualization.

Release Date: June 11, 2020
Expiration Date: June 11, 2021

Learn More & View Event »

A Virtual Reality Tour – The Role of Risk Evaluation in Minimizing Recurrence and Metastasis in Patients with cSCC Undergoing Surgical Intervention

A Virtual Reality Tour – The Role of Risk Evaluation in Minimizing Recurrence and Metastasis in Patients with cSCC Undergoing Surgical Intervention

This enduring activity is focused on the management of patients with advanced or metastatic cutaneous squamous cell carcinoma.

Release Date: June 12, 2020
Expiration Date: June 12, 2021

Learn More & View Event »

The Role of the Emergency Room Physician in the Diagnosis and Management of Neuromyelitis Optica Spectrum Disorder

The Role of the Emergency Room Physician in the Diagnosis and Management of Neuromyelitis Optica Spectrum Disorder

Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare, lifelong and debilitating autoimmune disease of the central nervous system (CNS), characterized by inflammation in the optic nerve and spinal cord. At this time there are no approved drugs to treat NMOSD. This program will focus on recognizing the symptoms and signs of NMOSD, reviewing best practices for early diagnosis of the disease, and discussing the novel mechanisms of action of emerging treatments for NMOSD and clinical trial data on their safety and efficacy profiles.

Release Date: June 30, 2020
Expiration Date: June 30, 2021

Learn More & View Event »

A Virtual Reality View: Incorporating GLP-1 Receptor Agonists into Clinical Practice: Personalizing Therapy to Improve Glycemic and Extra-glycemic Outcomes

A Virtual Reality View: Incorporating GLP-1 Receptor Agonists into Clinical Practice: Personalizing Therapy to Improve Glycemic and Extra-glycemic Outcomes

This case-based activity will cover the diagnosis, treatment, and management of patients with type 2 diabetes.

Release Date: June 30, 2020
Expiration Date: June 30, 2021

Learn More & View Event »
Scroll to Top

A Special Thank You to All HCPs

Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.

Connecting you with our personalized approach to continuing Medical Education

The Linking Approach to Education from Gap Analysis to Outcomes

Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.

Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.